Lung cancer survival rate improves but the disease still remains leading cause of cancer deaths
The survival rate for people with lung cancer is improving, according to the new State of Lung Cancer report. The American ...
Hosted on MSN1d
Woman Goes Blind In One Eye, Gets Diagnosed With Lung Cancer
“Despite widespread malignant involvement, the patient was completely asymptomatic and active except for visual disturbances. This case further emphasizes the necessity of prompt and priority-based ...
Lung Cancer Research Foundation and the International Association for the Study of Lung Cancer Announce First Team Science Award Grant
The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...
Medscape5d
An Update on the Evaluation and Management of Small Pulmonary Nodules
The widespread utilization of chest CT scans has increased the importance of the proper evaluation of incidentally found lung nodules. The primary goal in the evaluation of these nodules is to ...
Palm Beach Post22d
Lung cancer is a leading cause of cancer death for women — know the risks
K. Adam Lee, MD, Medical Director at the Thoracic Surgery & Lung Center of Excellence at Jupiter Medical Center, is here to share a message that affects every woman. Lung cancer is the leading ...
Covid19 Virus Has The Potential To Treat Cancer, As Per New Research
According to a recent study, Covid-19 may unanticipatedly help cancer patients by reducing malignant tumors, which may result ...
Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...
Cure Today12d
Ponsegromab May Aid Weight Gain in Patients With Cachexia
Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia ...
Alpha Biopharma Received NMPA Approval For Zorifertinib Tablets (Zorifer®), The World's First EGFR-TKI For Lung Cancer With Brain Metastases.
Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...
MM&M9d
Merck strikes $3.3B licensing deal for Chinese cancer drug
As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug ...